H.R. 6423

119 HR 6423 IH: Help Ensure Lower Patient Copays Act
 U.S. House of Representatives
 2025-12-04
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 6423  IN THE HOUSE OF REPRESENTATIVES   December 4, 2025   Mr. Kean  (for himself,  Ms. Barragán ,  Mrs. Miller-Meeks ,  Mr. Auchincloss ,  Mr. Fitzpatrick , and  Mrs. Watson Coleman ) introduced the following bill; which was referred to the  Committee on Energy and Commerce , and in addition to the Committee on  Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned   A BILL
To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes.
1.
Short title
This Act may be cited as the   Help Ensure Lower Patient Copays Act   or the   HELP Copays Act  .
2.
Application of financial assistance toward cost-sharing requirements
(a)
Application toward cost-Sharing requirements
Section 2715(g)(1) of the Public Health Service Act ( 42 U.S.C. 300gg–15(g)(1) ) is amended by adding at the end the following:  In developing the standards for defining the terms  deductible ,  coinsurance ,  copayment , and  out-of-pocket limit  (as described in paragraph (2)), such standards shall provide that such terms include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and that such amounts shall be counted toward such deductible, coinsurance, copayment, or limit, respectively. .
(b)
Conforming amendments
(1)
PPACA
Section 1302(c)(3) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(c)(3) ) is amended by adding at the end the following new subparagraph:
(C)
Application of terms
For purposes of subparagraph (A), the terms  deductible ,  coinsurance ,  copayment , or  similar charge  and any other expenditure described in clause (ii) of such subparagraph shall include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and such amounts shall be counted toward such deductible, co-insurance, co-payment, charge, or other expenditure, respectively.
 .
(2)
PHSA
Section 2707(b) of the Public Health Service Act ( 42 U.S.C. 300gg–6(b) ) is amended by adding at the end the following new sentence:  For purposes of the previous sentence, such limitation shall be applied to prescription drugs as if the reference to  essential health benefits  in section 1302(c)(3) of the Patient Protection and Affordable Care Act were a reference to  any item or service covered under the plan included within the prescription drug category of essential health benefits as described in (b)(1)(F) of such section . .
(3)
Internal Revenue Code of 1986 safe harbor for certain amounts applied to deductibles
 Section 223(c)(2)  of the Internal Revenue Code of 1986 is amended by adding at the end the following new subparagraph:
(H)
Safe harbor for certain amounts applied to deductibles
In the case of plan years beginning after December 31, 2025, a plan shall not fail to be treated as a high deductible health plan by reason of counting amounts paid by, or on behalf of, an individual, including financial assistance offered by non-profit organizations and prescription drug manufacturers for outpatient prescription drugs, when determining whether the minimum deductible under subparagraph (A) has been satisfied.
 .
(c)
Rule of construction
The amendments made by this section shall—
(1)
apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to prescription drugs that are specialty drugs;
(2)
apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to drugs that are subject to utilization management; and
(3)
not impact the use of utilization management tools, including prior authorization and step therapy.
(d)
Effective date
This section, and the amendments made by this section, shall apply to group health plans and health insurance issuers for plan years beginning on or after January 1, 2026.